These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 14665352)
21. Performance of a neural network in detecting prostate cancer in the prostate-specific antigen reflex range of 2.5 to 4.0 ng/mL. Babaian RJ; Fritsche H; Ayala A; Bhadkamkar V; Johnston DA; Naccarato W; Zhang Z Urology; 2000 Dec; 56(6):1000-6. PubMed ID: 11113747 [TBL] [Abstract][Full Text] [Related]
22. Geographic distribution of prostate cancer incidence in the era of PSA testing, Connecticut, 1984 to 1998. Gregorio DI; Kulldorff M; Sheehan TJ; Samociuk H Urology; 2004 Jan; 63(1):78-82. PubMed ID: 14751353 [TBL] [Abstract][Full Text] [Related]
23. Can the number of cores with high-grade prostate intraepithelial neoplasia predict cancer in men who undergo repeat biopsy? Naya Y; Ayala AG; Tamboli P; Babaian RJ Urology; 2004 Mar; 63(3):503-8. PubMed ID: 15028446 [TBL] [Abstract][Full Text] [Related]
24. Age and PSA predict likelihood of organ-confined disease in men presenting with PSA less than 10 ng/mL: implications for screening. Aleman M; Karakiewicz PI; Kupelian P; Kattan MW; Graefen M; Cagiannos I; Eastham J; Scardino PT; Huland H; Klein EA Urology; 2003 Jul; 62(1):70-4. PubMed ID: 12837425 [TBL] [Abstract][Full Text] [Related]
25. [Echo-guided biopsy of the transitional zone in the diagnosis of prostatic carcinoma]. Pagliarulo A; Curatolo C; Cirillo Marucco E; Lorusso A; Limitone DA; Ludovico GM Arch Ital Urol Androl; 1996 Dec; 68(5 Suppl):221-4. PubMed ID: 9162367 [TBL] [Abstract][Full Text] [Related]
26. Serial prostate specific antigen, free-to-total prostate specific antigen ratio and complexed prostate specific antigen for the diagnosis of prostate cancer. Ellis WJ; Etzioni R; Vessella RL; Hu C; Goodman GE J Urol; 2001 Jul; 166(1):93-8; discussion 98-9. PubMed ID: 11435831 [TBL] [Abstract][Full Text] [Related]
27. Radical retropubic prostatectomy in men younger than 45 years diagnosed during early prostate cancer detection program. Varkarakis J; Pinggera GM; Sebe P; Berger A; Bartsch G; Horninger W Urology; 2004 Feb; 63(2):337-41. PubMed ID: 14972485 [TBL] [Abstract][Full Text] [Related]
28. Prostate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Economic Analysis. Tawfik A Ont Health Technol Assess Ser; 2015; 15(11):1-37. PubMed ID: 26366237 [TBL] [Abstract][Full Text] [Related]
29. [Prostate cancer screening using prostate-specific antigen (PSA) determinations in plasma. National Academy of Medicine]. Bourel M; Ardaillou R; Bull Acad Natl Med; 2003; 187(5):985-95. PubMed ID: 14979060 [TBL] [Abstract][Full Text] [Related]
30. Positive and negative biopsies in the pre-prostate specific antigen and prostate specific antigen eras, 1980 to 1997. Roberts RO; Bergstralh EJ; Peterson NR; Bostwick DG; Lieber MM; Jacobsen SJ J Urol; 2000 May; 163(5):1471-5. PubMed ID: 10751860 [TBL] [Abstract][Full Text] [Related]
31. Use of low free to total PSA ratio in prostate cancer screening: detection rates, clinical and pathological findings in Brazilian men with serum PSA levels <4.0 ng/mL. Faria EF; Carvalhal GF; dos Reis RB; Tobias-Machado M; Vieira RA; Reis LO; Nogueira L; Machado RD; Freitas CH; Magnabosco WJ; Mauad EC; Carvalho AL BJU Int; 2012 Dec; 110(11 Pt B):E653-7. PubMed ID: 22892057 [TBL] [Abstract][Full Text] [Related]
32. Single small focus of prostate adenocarcinoma (< or = 1 mm and too small for grading) and clinical significant disease after radical prostatectomy. Taverna G; Colombo P; Seveso M; Giusti G; Piccinelli A; Benetti A; Graziotti P Arch Ital Urol Androl; 2006 Jun; 78(2):57-60. PubMed ID: 16929604 [TBL] [Abstract][Full Text] [Related]
33. Features of prostate cancers detected during a prevalence screening round. The Rotterdam experience. Van der Kwast TH; Postma R; Hoedemaeker RF; van Leenders GJ; Schröder FH Can J Urol; 2005 Jun; 12 Suppl 2():16-20. PubMed ID: 16018827 [TBL] [Abstract][Full Text] [Related]
34. Impact of Accountable Care Organizations on Diagnostic Testing for Prostate Cancer. Luckenbaugh AN; Hollenbeck BK; Kaufman SR; Yan P; Herrel LA; Skolarus TA; Norton EC; Schroeck FR; Jacobs BL; Miller DC; Hollingsworth JM; Shahinian VB; Borza T Urology; 2018 Jun; 116():68-75. PubMed ID: 29630957 [TBL] [Abstract][Full Text] [Related]
35. US Preventive Services Task Force prostate-specific antigen screening guidelines result in higher Gleason score diagnoses. Gejerman G; Ciccone P; Goldstein M; Lanteri V; Schlecker B; Sanzone J; Esposito M; Rome S; Ciccone M; Margolis E; Simon R; Guo Y; Pentakota SR; Sadeghi-Nejad H Investig Clin Urol; 2017 Nov; 58(6):423-428. PubMed ID: 29124241 [TBL] [Abstract][Full Text] [Related]
36. Saturation biopsy technique increase the capacity to diagnose adenocarcinoma of prostate in patients with PSA < 10 ng/ml, after a first negative biopsy. Giulianelli R; Brunori S; Gentile BC; Vincenti G; Nardoni S; Pisanti F; Shestani T; Mavilla L; Albanesi L; Attisani F; Mirabile G; Schettini M Arch Ital Urol Androl; 2011 Sep; 83(3):154-9. PubMed ID: 22184840 [TBL] [Abstract][Full Text] [Related]
40. Detection rate of prostate cancer following biopsy among the northern Han Chinese population: a single-center retrospective study of 1022 cases. Jia Y; Zhu LY; Xian YX; Sun XQ; Gao JG; Zhang XH; Hou SC; Zhang CC; Liu ZX World J Surg Oncol; 2017 Aug; 15(1):165. PubMed ID: 28851376 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]